HRTX logo

Heron Therapeutics (HRTX) Net Margin

Annual Net Margin

-87.02%
+82.03%+48.52%

31 December 2023

HRTX Net Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Margin

-14.78%
+10.86%+42.36%

30 September 2024

HRTX Quarterly Net Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HRTX Net Margin Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+48.5%+81.4%
3 y3 years+66.1%+93.5%
5 y5 years+62.3%+81.3%

HRTX Net Margin High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+66.1%-62.2%+94.6%
5 y5 yearsat high+66.1%-62.2%+95.1%
alltimeall time-731.1%+99.4%-123.3%+100.0%

Heron Therapeutics Net Margin History

DateAnnualQuarterly
Sept 2024
-
-14.78%(-42.4%)
June 2024
-
-25.64%(+181.4%)
Mar 2024
-
-9.11%(-70.9%)
Dec 2023
-87.02%(-48.5%)
-31.33%(-60.6%)
Sept 2023
-
-79.56%(-39.9%)
June 2023
-
-132.42%(+19.7%)
Mar 2023
-
-110.65%(+67.2%)
Dec 2022
-169.05%(-33.9%)
-66.17%(-58.1%)
Sept 2022
-
-157.80%(-22.6%)
June 2022
-
-203.98%(-25.1%)
Mar 2022
-
-272.36%(+2.9%)
Dec 2021
-255.58%(-0.3%)
-264.57%(+17.3%)
Sept 2021
-
-225.60%(-17.0%)
June 2021
-
-271.87%(+3.4%)
Mar 2021
-
-262.83%(-13.0%)
Dec 2020
-256.41%(+82.8%)
-302.26%(+3.6%)
Sept 2020
-
-291.65%(+19.8%)
June 2020
-
-243.47%(+19.9%)
Mar 2020
-
-203.07%(+23.0%)
Dec 2019
-140.27%(-39.2%)
-165.09%(+109.5%)
Sept 2019
-
-78.82%(-42.5%)
June 2019
-
-137.00%(-31.3%)
Mar 2019
-
-199.39%(+16.0%)
Dec 2018
-230.84%(-64.0%)
-171.82%(-11.3%)
Sept 2018
-
-193.80%(-13.4%)
June 2018
-
-223.82%(-50.5%)
Mar 2018
-
-451.85%(-27.3%)
Dec 2017
-641.87%(-95.3%)
-621.61%(+27.3%)
Sept 2017
-
-488.40%(-2.9%)
June 2017
-
-502.93%(-63.7%)
Mar 2017
-
-1385.71%(-63.0%)
Dec 2016
-13.54 K%(+640.2%)
-3750.04%(+387.2%)
Dec 2011
-1828.79%(+223.9%)
-
June 2011
-
-769.72%(+114.3%)
Mar 2011
-
-359.24%(-59.7%)
Dec 2010
-564.64%(-29.0%)
-891.62%(+87.2%)
Sept 2010
-
-476.35%(-29.5%)
June 2010
-
-676.04%(+229.1%)
Mar 2010
-
-205.39%(-86.9%)
Dec 2009
-795.24%(-87.3%)
-1568.03%(+1342.8%)
Sept 2009
-
-108.68%(-99.6%)
June 2009
-
-28.15 K%(-23.9%)
Mar 2009
-
-37.00 K%(+96.9%)
Dec 2008
-6266.94%(+28.1%)
-18.79 K%(+93.8%)
Sept 2008
-
-9695.31%(+140.4%)
June 2008
-
-4032.89%(-21.6%)
Mar 2008
-
-5145.86%(-11.8%)
Dec 2007
-4893.93%(+3113.6%)
-5834.09%(+50.7%)
Sept 2007
-
-3871.90%(+248.8%)
June 2007
-
-1110.00%(+515.8%)
Dec 2005
-152.29%(-10.7%)
-180.26%(+38.2%)
Sept 2005
-
-130.44%(-37.5%)
June 2005
-
-208.64%(+125.9%)
Mar 2005
-
-92.35%(-39.4%)
Dec 2004
-170.63%(+89.6%)
-152.29%(+15.6%)
Sept 2004
-
-131.76%(-30.8%)
June 2004
-
-190.34%(-13.6%)
Mar 2004
-
-220.25%(+117.1%)
Dec 2003
-90.00%
-101.47%(+21.6%)
Sept 2003
-
-83.44%(-52.4%)
June 2003
-
-175.47%(-5815.6%)
DateAnnualQuarterly
Mar 2003
-
3.07%(-111.4%)
Dec 2002
-80.90%(+5.1%)
-26.99%(-65.5%)
Sept 2002
-
-78.33%(-34.5%)
June 2002
-
-119.54%(+13.1%)
Mar 2002
-
-105.67%(-79.6%)
Dec 2001
-77.00%(+72.3%)
-518.29%(+332.9%)
June 2001
-
-119.72%(+3.7%)
Mar 2001
-
-115.49%(-36.2%)
Dec 2000
-
-180.92%(+148.1%)
June 2000
-
-72.92%(-341.7%)
Mar 2000
-
30.17%(-107.7%)
Dec 1999
-44.68%(-48.7%)
-393.17%(-719.6%)
Sept 1999
-
63.46%(+894.7%)
June 1999
-
6.38%(+2.1%)
Mar 1999
-
6.25%(-86.2%)
Dec 1998
-87.10%(+731.9%)
45.45%(+345.6%)
Sept 1998
-
10.20%(+160.2%)
June 1998
-
3.92%(-111.4%)
Dec 1997
-10.47%(-79.2%)
-34.29%(+251.3%)
Sept 1997
-
-9.76%(-26.8%)
June 1997
-
-13.33%(-266.6%)
Mar 1997
-
8.00%(-109.5%)
Dec 1996
-50.27%(-13.9%)
-84.21%(+76.4%)
Sept 1996
-
-47.73%(+22.7%)
June 1996
-
-38.89%(+1.1%)
Mar 1996
-
-38.46%(-72.7%)
Dec 1995
-58.39%(-5.3%)
-140.63%(+118.0%)
Sept 1995
-
-64.52%(+51.6%)
June 1995
-
-42.55%(+141.1%)
Mar 1995
-
-17.65%(-78.8%)
Dec 1994
-61.64%(+23.9%)
-83.33%(+4.9%)
Sept 1994
-
-79.41%(+29.4%)
June 1994
-
-61.36%(+73.9%)
Mar 1994
-
-35.29%(-45.4%)
Dec 1993
-49.75%(-35.1%)
-64.58%(+5.9%)
Sept 1993
-
-60.98%(+11.1%)
June 1993
-
-54.90%(-23.8%)
Mar 1993
-
-72.00%(-4.0%)
Dec 1992
-76.71%(-50.0%)
-75.00%(+66.7%)
Sept 1992
-
-45.00%(-1.0%)
June 1992
-
-45.45%(-83.3%)
Mar 1992
-
-271.43%(-27.6%)
Dec 1991
-153.57%(-5.5%)
-375.00%(+56.3%)
Sept 1991
-
-240.00%(+620.1%)
June 1991
-
-33.33%(-87.9%)
Mar 1991
-
-275.00%(+220.8%)
Dec 1990
-162.50%(+1.1%)
-85.71%(-71.4%)
Sept 1990
-
-300.00%(+118.2%)
June 1990
-
-137.50%(-8.3%)
Mar 1990
-
-150.00%(-18.2%)
Dec 1989
-160.71%(-19.6%)
-183.33%(+1.8%)
Sept 1989
-
-180.00%(+160.0%)
June 1989
-
-69.23%(-76.9%)
Mar 1989
-
-300.00%(-21.1%)
Dec 1988
-200.00%(-10.5%)
-380.00%(+52.0%)
Sept 1988
-
-250.00%(+13.6%)
June 1988
-
-220.00%(+296.0%)
Mar 1988
-
-55.56%(-51.4%)
Dec 1987
-223.53%
-114.29%(-71.4%)
Sept 1987
-
-400.00%(+77.8%)
June 1987
-
-225.00%(-25.0%)
Mar 1987
-
-300.00%

FAQ

  • What is Heron Therapeutics annual net profit margin?
  • What is the all time high annual net margin for Heron Therapeutics?
  • What is Heron Therapeutics annual net margin year-on-year change?
  • What is Heron Therapeutics quarterly net profit margin?
  • What is the all time high quarterly net margin for Heron Therapeutics?
  • What is Heron Therapeutics quarterly net margin year-on-year change?

What is Heron Therapeutics annual net profit margin?

The current annual net margin of HRTX is -87.02%

What is the all time high annual net margin for Heron Therapeutics?

Heron Therapeutics all-time high annual net profit margin is -10.47%

What is Heron Therapeutics annual net margin year-on-year change?

Over the past year, HRTX annual net profit margin has changed by +82.03% (+48.52%)

What is Heron Therapeutics quarterly net profit margin?

The current quarterly net margin of HRTX is -14.78%

What is the all time high quarterly net margin for Heron Therapeutics?

Heron Therapeutics all-time high quarterly net profit margin is 63.46%

What is Heron Therapeutics quarterly net margin year-on-year change?

Over the past year, HRTX quarterly net profit margin has changed by +64.78% (+81.42%)